Cyclosporine-Induced Hypertension and Hyperlipidemia: A Practical Guide for Advanced Practice Providers
Journal of the Advanced Practitioner in Oncology · 09.11.2026 · 17 (7)
DOI: 10.6004/jadpro.2026.17.7.33 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Advanced Practitioner in Oncology, online erschienen am 09.11.2026. Verfasst von Alexis Geppner und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Cyclosporine A (CsA) is a widely used calcineurin inhibitor essential for immunosuppression in solid organ and hematopoietic stem cell transplantation (HSCT), immune-mediated bone marrow failure, and autoimmune diseases.Although highly efficacious as an immunosuppressive agent, its use is associated with clinically significant cardiovascular and metabolic adverse effects, most prominently hypertension and hyperlipidemia.These adverse effects arise through well-characterized mechanisms, including renal vasoconstriction, endothelial dysfunction, and alterations in lipid metabolism.Advanced practice providers (APPs) play a crucial role in the longitudinal care of patients receiving cyclosporine and must possess a comprehensive understanding of these complications to optimize patient outcomes.While CsA also has notable effects of nephrotoxicity, hepatotoxicity, and neurotoxicity, these will not be discussed in this review.Synthesizing current peer-reviewed literature, this practical guide examines the pathophysiologic mechanisms underlying CsA-induced hypertension and hyperlipidemia, outlines evidence-based monitoring strategies, and provides clinically actionable management recommendations tailored to the APP's scope of practice across oncology, transplant, and immunology settings.
Zitieren
APA
Geppner, A., MLS, CTTS, MPAS, & PA-C (2026). Cyclosporine-Induced Hypertension and Hyperlipidemia: A Practical Guide for Advanced Practice Providers. Journal of the Advanced Practitioner in Oncology, 17(7). https://doi.org/10.6004/jadpro.2026.17.7.33
Vancouver
Geppner A, MLS, CTTS, MPAS, PA-C. Cyclosporine-Induced Hypertension and Hyperlipidemia: A Practical Guide for Advanced Practice Providers. Journal of the Advanced Practitioner in Oncology. 2026;17(7). doi:10.6004/jadpro.2026.17.7.33
BibTeX
@article{Geppner2026,
author = {Geppner, Alexis and MLS and CTTS and MPAS and PA-C},
title = {Cyclosporine-Induced Hypertension and Hyperlipidemia: A Practical Guide for Advanced Practice Providers},
journal = {Journal of the Advanced Practitioner in Oncology},
year = {2026},
volume = {17},
number = {7},
doi = {10.6004/jadpro.2026.17.7.33}
}
EUVIMED